Global Newcastle Disease Vaccine Supply, Demand and Key Producers, 2026-2032
The global Newcastle Disease Vaccine market size is expected to reach $ 443 million by 2032, rising at a market growth of 3.2% CAGR during the forecast period (2026-2032).
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology and Yebio, etc. are the leader of this industry. They got about 63% market shares. Asia-Pacific is the largest consumption place, with a consumption market share nearly 56%. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of 2%.
This report studies the global Newcastle Disease Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Newcastle Disease Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Newcastle Disease Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Newcastle Disease Vaccine total production and demand, 2021-2032, (M Doses)
Global Newcastle Disease Vaccine total production value, 2021-2032, (USD Million)
Global Newcastle Disease Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Doses), (based on production site)
Global Newcastle Disease Vaccine consumption by region & country, CAGR, 2021-2032 & (M Doses)
U.S. VS China: Newcastle Disease Vaccine domestic production, consumption, key domestic manufacturers and share
Global Newcastle Disease Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Doses)
Global Newcastle Disease Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Doses)
Global Newcastle Disease Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (M Doses)
This report profiles key players in the global Newcastle Disease Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merial, CEVA, QYH Biotech, Ringpu Biology, Yebio, Harbin Veterinary Research Institute, Merck Animal Health, DHN, Zoetis, ChengDu Tecbond, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Newcastle Disease Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Doses) and average price (USD/K Doses) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Newcastle Disease Vaccine Market, By Region:
1. How big is the global Newcastle Disease Vaccine market?
2. What is the demand of the global Newcastle Disease Vaccine market?
3. What is the year over year growth of the global Newcastle Disease Vaccine market?
4. What is the production and production value of the global Newcastle Disease Vaccine market?
5. Who are the key producers in the global Newcastle Disease Vaccine market?
6. What are the growth factors driving the market demand?
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology and Yebio, etc. are the leader of this industry. They got about 63% market shares. Asia-Pacific is the largest consumption place, with a consumption market share nearly 56%. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of 2%.
This report studies the global Newcastle Disease Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Newcastle Disease Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Newcastle Disease Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Newcastle Disease Vaccine total production and demand, 2021-2032, (M Doses)
Global Newcastle Disease Vaccine total production value, 2021-2032, (USD Million)
Global Newcastle Disease Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Doses), (based on production site)
Global Newcastle Disease Vaccine consumption by region & country, CAGR, 2021-2032 & (M Doses)
U.S. VS China: Newcastle Disease Vaccine domestic production, consumption, key domestic manufacturers and share
Global Newcastle Disease Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Doses)
Global Newcastle Disease Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Doses)
Global Newcastle Disease Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (M Doses)
This report profiles key players in the global Newcastle Disease Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merial, CEVA, QYH Biotech, Ringpu Biology, Yebio, Harbin Veterinary Research Institute, Merck Animal Health, DHN, Zoetis, ChengDu Tecbond, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Newcastle Disease Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Doses) and average price (USD/K Doses) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Newcastle Disease Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Live Vaccines
- Killed Vaccines
- Chicken
- Duck & Goose
- Other
- Merial
- CEVA
- QYH Biotech
- Ringpu Biology
- Yebio
- Harbin Veterinary Research Institute
- Merck Animal Health
- DHN
- Zoetis
- ChengDu Tecbond
- Elanco (Lohmann)
- FATRO
- CAVAC
- Vaksindo
1. How big is the global Newcastle Disease Vaccine market?
2. What is the demand of the global Newcastle Disease Vaccine market?
3. What is the year over year growth of the global Newcastle Disease Vaccine market?
4. What is the production and production value of the global Newcastle Disease Vaccine market?
5. Who are the key producers in the global Newcastle Disease Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 SCADA Introduction
1.2 World SCADA Market Size & Forecast (2021 & 2025 & 2032)
1.3 World SCADA Total Market by Region (by Headquarter Location)
1.3.1 World SCADA Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company SCADA Revenue (2021-2032)
1.3.3 China Based Company SCADA Revenue (2021-2032)
1.3.4 Europe Based Company SCADA Revenue (2021-2032)
1.3.5 Japan Based Company SCADA Revenue (2021-2032)
1.3.6 South Korea Based Company SCADA Revenue (2021-2032)
1.3.7 ASEAN Based Company SCADA Revenue (2021-2032)
1.3.8 India Based Company SCADA Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 SCADA Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World SCADA Consumption Value (2021-2032)
2.2 World SCADA Consumption Value by Region
2.2.1 World SCADA Consumption Value by Region (2021-2026)
2.2.2 World SCADA Consumption Value Forecast by Region (2027-2032)
2.3 United States SCADA Consumption Value (2021-2032)
2.4 China SCADA Consumption Value (2021-2032)
2.5 Europe SCADA Consumption Value (2021-2032)
2.6 Japan SCADA Consumption Value (2021-2032)
2.7 South Korea SCADA Consumption Value (2021-2032)
2.8 ASEAN SCADA Consumption Value (2021-2032)
2.9 India SCADA Consumption Value (2021-2032)
3 WORLD SCADA COMPANIES COMPETITIVE ANALYSIS
3.1 World SCADA Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global SCADA Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for SCADA in 2025
3.2.3 Global Concentration Ratios (CR8) for SCADA in 2025
3.3 SCADA Company Evaluation Quadrant
3.4 SCADA Market: Overall Company Footprint Analysis
3.4.1 SCADA Market: Region Footprint
3.4.2 SCADA Market: Company Product Type Footprint
3.4.3 SCADA Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: SCADA Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: SCADA Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: SCADA Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: SCADA Consumption Value Comparison
4.2.1 United States VS China: SCADA Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: SCADA Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based SCADA Companies and Market Share, 2021-2026
4.3.1 United States Based SCADA Companies, Headquarters (States, Country)
4.3.2 United States Based Companies SCADA Revenue, (2021-2026)
4.4 China Based Companies SCADA Revenue and Market Share, 2021-2026
4.4.1 China Based SCADA Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies SCADA Revenue, (2021-2026)
4.5 Rest of World Based SCADA Companies and Market Share, 2021-2026
4.5.1 Rest of World Based SCADA Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies SCADA Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World SCADA Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Hardware
5.2.2 Software
5.2.3 Services
5.3 Market Segment by Type
5.3.1 World SCADA Market Size by Type (2021-2026)
5.3.2 World SCADA Market Size by Type (2027-2032)
5.3.3 World SCADA Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World SCADA Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Power & Energy
6.2.2 Oil & Gas Industry
6.2.3 Water & Waste Control
6.2.4 Telecommunications
6.2.5 Transportation
6.2.6 Manufacturing Industry
6.2.7 Others
6.3 Market Segment by Application
6.3.1 World SCADA Market Size by Application (2021-2026)
6.3.2 World SCADA Market Size by Application (2027-2032)
6.3.3 World SCADA Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Schneider Electric SE (France)
7.1.1 Schneider Electric SE (France) Details
7.1.2 Schneider Electric SE (France) Major Business
7.1.3 Schneider Electric SE (France) SCADA Product and Services
7.1.4 Schneider Electric SE (France) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Schneider Electric SE (France) Recent Developments/Updates
7.1.6 Schneider Electric SE (France) Competitive Strengths & Weaknesses
7.2 ABB (Switzerland)
7.2.1 ABB (Switzerland) Details
7.2.2 ABB (Switzerland) Major Business
7.2.3 ABB (Switzerland) SCADA Product and Services
7.2.4 ABB (Switzerland) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 ABB (Switzerland) Recent Developments/Updates
7.2.6 ABB (Switzerland) Competitive Strengths & Weaknesses
7.3 Siemens AG (Germany)
7.3.1 Siemens AG (Germany) Details
7.3.2 Siemens AG (Germany) Major Business
7.3.3 Siemens AG (Germany) SCADA Product and Services
7.3.4 Siemens AG (Germany) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Siemens AG (Germany) Recent Developments/Updates
7.3.6 Siemens AG (Germany) Competitive Strengths & Weaknesses
7.4 Emerson (US)
7.4.1 Emerson (US) Details
7.4.2 Emerson (US) Major Business
7.4.3 Emerson (US) SCADA Product and Services
7.4.4 Emerson (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Emerson (US) Recent Developments/Updates
7.4.6 Emerson (US) Competitive Strengths & Weaknesses
7.5 Rockwell Automation Inc. (US)
7.5.1 Rockwell Automation Inc. (US) Details
7.5.2 Rockwell Automation Inc. (US) Major Business
7.5.3 Rockwell Automation Inc. (US) SCADA Product and Services
7.5.4 Rockwell Automation Inc. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Rockwell Automation Inc. (US) Recent Developments/Updates
7.5.6 Rockwell Automation Inc. (US) Competitive Strengths & Weaknesses
7.6 Honeywell International Inc. (US)
7.6.1 Honeywell International Inc. (US) Details
7.6.2 Honeywell International Inc. (US) Major Business
7.6.3 Honeywell International Inc. (US) SCADA Product and Services
7.6.4 Honeywell International Inc. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Honeywell International Inc. (US) Recent Developments/Updates
7.6.6 Honeywell International Inc. (US) Competitive Strengths & Weaknesses
7.7 Mitsubishi Electric (Japan)
7.7.1 Mitsubishi Electric (Japan) Details
7.7.2 Mitsubishi Electric (Japan) Major Business
7.7.3 Mitsubishi Electric (Japan) SCADA Product and Services
7.7.4 Mitsubishi Electric (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Mitsubishi Electric (Japan) Recent Developments/Updates
7.7.6 Mitsubishi Electric (Japan) Competitive Strengths & Weaknesses
7.8 Omron Corporation (Japan)
7.8.1 Omron Corporation (Japan) Details
7.8.2 Omron Corporation (Japan) Major Business
7.8.3 Omron Corporation (Japan) SCADA Product and Services
7.8.4 Omron Corporation (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Omron Corporation (Japan) Recent Developments/Updates
7.8.6 Omron Corporation (Japan) Competitive Strengths & Weaknesses
7.9 General Electric Co. (US)
7.9.1 General Electric Co. (US) Details
7.9.2 General Electric Co. (US) Major Business
7.9.3 General Electric Co. (US) SCADA Product and Services
7.9.4 General Electric Co. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 General Electric Co. (US) Recent Developments/Updates
7.9.6 General Electric Co. (US) Competitive Strengths & Weaknesses
7.10 Yokogawa Electric Corporation (Japan)
7.10.1 Yokogawa Electric Corporation (Japan) Details
7.10.2 Yokogawa Electric Corporation (Japan) Major Business
7.10.3 Yokogawa Electric Corporation (Japan) SCADA Product and Services
7.10.4 Yokogawa Electric Corporation (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Yokogawa Electric Corporation (Japan) Recent Developments/Updates
7.10.6 Yokogawa Electric Corporation (Japan) Competitive Strengths & Weaknesses
7.11 Larsen & Toubro (India)
7.11.1 Larsen & Toubro (India) Details
7.11.2 Larsen & Toubro (India) Major Business
7.11.3 Larsen & Toubro (India) SCADA Product and Services
7.11.4 Larsen & Toubro (India) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Larsen & Toubro (India) Recent Developments/Updates
7.11.6 Larsen & Toubro (India) Competitive Strengths & Weaknesses
7.12 M.B. Control & Systems Pvt. Ltd (India)
7.12.1 M.B. Control & Systems Pvt. Ltd (India) Details
7.12.2 M.B. Control & Systems Pvt. Ltd (India) Major Business
7.12.3 M.B. Control & Systems Pvt. Ltd (India) SCADA Product and Services
7.12.4 M.B. Control & Systems Pvt. Ltd (India) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 M.B. Control & Systems Pvt. Ltd (India) Recent Developments/Updates
7.12.6 M.B. Control & Systems Pvt. Ltd (India) Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 SCADA Industry Chain
8.2 SCADA Upstream Analysis
8.3 SCADA Midstream Analysis
8.4 SCADA Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 SCADA Introduction
1.2 World SCADA Market Size & Forecast (2021 & 2025 & 2032)
1.3 World SCADA Total Market by Region (by Headquarter Location)
1.3.1 World SCADA Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company SCADA Revenue (2021-2032)
1.3.3 China Based Company SCADA Revenue (2021-2032)
1.3.4 Europe Based Company SCADA Revenue (2021-2032)
1.3.5 Japan Based Company SCADA Revenue (2021-2032)
1.3.6 South Korea Based Company SCADA Revenue (2021-2032)
1.3.7 ASEAN Based Company SCADA Revenue (2021-2032)
1.3.8 India Based Company SCADA Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 SCADA Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World SCADA Consumption Value (2021-2032)
2.2 World SCADA Consumption Value by Region
2.2.1 World SCADA Consumption Value by Region (2021-2026)
2.2.2 World SCADA Consumption Value Forecast by Region (2027-2032)
2.3 United States SCADA Consumption Value (2021-2032)
2.4 China SCADA Consumption Value (2021-2032)
2.5 Europe SCADA Consumption Value (2021-2032)
2.6 Japan SCADA Consumption Value (2021-2032)
2.7 South Korea SCADA Consumption Value (2021-2032)
2.8 ASEAN SCADA Consumption Value (2021-2032)
2.9 India SCADA Consumption Value (2021-2032)
3 WORLD SCADA COMPANIES COMPETITIVE ANALYSIS
3.1 World SCADA Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global SCADA Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for SCADA in 2025
3.2.3 Global Concentration Ratios (CR8) for SCADA in 2025
3.3 SCADA Company Evaluation Quadrant
3.4 SCADA Market: Overall Company Footprint Analysis
3.4.1 SCADA Market: Region Footprint
3.4.2 SCADA Market: Company Product Type Footprint
3.4.3 SCADA Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: SCADA Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: SCADA Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: SCADA Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: SCADA Consumption Value Comparison
4.2.1 United States VS China: SCADA Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: SCADA Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based SCADA Companies and Market Share, 2021-2026
4.3.1 United States Based SCADA Companies, Headquarters (States, Country)
4.3.2 United States Based Companies SCADA Revenue, (2021-2026)
4.4 China Based Companies SCADA Revenue and Market Share, 2021-2026
4.4.1 China Based SCADA Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies SCADA Revenue, (2021-2026)
4.5 Rest of World Based SCADA Companies and Market Share, 2021-2026
4.5.1 Rest of World Based SCADA Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies SCADA Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World SCADA Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Hardware
5.2.2 Software
5.2.3 Services
5.3 Market Segment by Type
5.3.1 World SCADA Market Size by Type (2021-2026)
5.3.2 World SCADA Market Size by Type (2027-2032)
5.3.3 World SCADA Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World SCADA Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Power & Energy
6.2.2 Oil & Gas Industry
6.2.3 Water & Waste Control
6.2.4 Telecommunications
6.2.5 Transportation
6.2.6 Manufacturing Industry
6.2.7 Others
6.3 Market Segment by Application
6.3.1 World SCADA Market Size by Application (2021-2026)
6.3.2 World SCADA Market Size by Application (2027-2032)
6.3.3 World SCADA Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Schneider Electric SE (France)
7.1.1 Schneider Electric SE (France) Details
7.1.2 Schneider Electric SE (France) Major Business
7.1.3 Schneider Electric SE (France) SCADA Product and Services
7.1.4 Schneider Electric SE (France) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Schneider Electric SE (France) Recent Developments/Updates
7.1.6 Schneider Electric SE (France) Competitive Strengths & Weaknesses
7.2 ABB (Switzerland)
7.2.1 ABB (Switzerland) Details
7.2.2 ABB (Switzerland) Major Business
7.2.3 ABB (Switzerland) SCADA Product and Services
7.2.4 ABB (Switzerland) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 ABB (Switzerland) Recent Developments/Updates
7.2.6 ABB (Switzerland) Competitive Strengths & Weaknesses
7.3 Siemens AG (Germany)
7.3.1 Siemens AG (Germany) Details
7.3.2 Siemens AG (Germany) Major Business
7.3.3 Siemens AG (Germany) SCADA Product and Services
7.3.4 Siemens AG (Germany) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Siemens AG (Germany) Recent Developments/Updates
7.3.6 Siemens AG (Germany) Competitive Strengths & Weaknesses
7.4 Emerson (US)
7.4.1 Emerson (US) Details
7.4.2 Emerson (US) Major Business
7.4.3 Emerson (US) SCADA Product and Services
7.4.4 Emerson (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Emerson (US) Recent Developments/Updates
7.4.6 Emerson (US) Competitive Strengths & Weaknesses
7.5 Rockwell Automation Inc. (US)
7.5.1 Rockwell Automation Inc. (US) Details
7.5.2 Rockwell Automation Inc. (US) Major Business
7.5.3 Rockwell Automation Inc. (US) SCADA Product and Services
7.5.4 Rockwell Automation Inc. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Rockwell Automation Inc. (US) Recent Developments/Updates
7.5.6 Rockwell Automation Inc. (US) Competitive Strengths & Weaknesses
7.6 Honeywell International Inc. (US)
7.6.1 Honeywell International Inc. (US) Details
7.6.2 Honeywell International Inc. (US) Major Business
7.6.3 Honeywell International Inc. (US) SCADA Product and Services
7.6.4 Honeywell International Inc. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Honeywell International Inc. (US) Recent Developments/Updates
7.6.6 Honeywell International Inc. (US) Competitive Strengths & Weaknesses
7.7 Mitsubishi Electric (Japan)
7.7.1 Mitsubishi Electric (Japan) Details
7.7.2 Mitsubishi Electric (Japan) Major Business
7.7.3 Mitsubishi Electric (Japan) SCADA Product and Services
7.7.4 Mitsubishi Electric (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Mitsubishi Electric (Japan) Recent Developments/Updates
7.7.6 Mitsubishi Electric (Japan) Competitive Strengths & Weaknesses
7.8 Omron Corporation (Japan)
7.8.1 Omron Corporation (Japan) Details
7.8.2 Omron Corporation (Japan) Major Business
7.8.3 Omron Corporation (Japan) SCADA Product and Services
7.8.4 Omron Corporation (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Omron Corporation (Japan) Recent Developments/Updates
7.8.6 Omron Corporation (Japan) Competitive Strengths & Weaknesses
7.9 General Electric Co. (US)
7.9.1 General Electric Co. (US) Details
7.9.2 General Electric Co. (US) Major Business
7.9.3 General Electric Co. (US) SCADA Product and Services
7.9.4 General Electric Co. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 General Electric Co. (US) Recent Developments/Updates
7.9.6 General Electric Co. (US) Competitive Strengths & Weaknesses
7.10 Yokogawa Electric Corporation (Japan)
7.10.1 Yokogawa Electric Corporation (Japan) Details
7.10.2 Yokogawa Electric Corporation (Japan) Major Business
7.10.3 Yokogawa Electric Corporation (Japan) SCADA Product and Services
7.10.4 Yokogawa Electric Corporation (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Yokogawa Electric Corporation (Japan) Recent Developments/Updates
7.10.6 Yokogawa Electric Corporation (Japan) Competitive Strengths & Weaknesses
7.11 Larsen & Toubro (India)
7.11.1 Larsen & Toubro (India) Details
7.11.2 Larsen & Toubro (India) Major Business
7.11.3 Larsen & Toubro (India) SCADA Product and Services
7.11.4 Larsen & Toubro (India) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Larsen & Toubro (India) Recent Developments/Updates
7.11.6 Larsen & Toubro (India) Competitive Strengths & Weaknesses
7.12 M.B. Control & Systems Pvt. Ltd (India)
7.12.1 M.B. Control & Systems Pvt. Ltd (India) Details
7.12.2 M.B. Control & Systems Pvt. Ltd (India) Major Business
7.12.3 M.B. Control & Systems Pvt. Ltd (India) SCADA Product and Services
7.12.4 M.B. Control & Systems Pvt. Ltd (India) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 M.B. Control & Systems Pvt. Ltd (India) Recent Developments/Updates
7.12.6 M.B. Control & Systems Pvt. Ltd (India) Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 SCADA Industry Chain
8.2 SCADA Upstream Analysis
8.3 SCADA Midstream Analysis
8.4 SCADA Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Newcastle Disease Vaccine Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Newcastle Disease Vaccine Production Value by Region (2021-2026) & (USD Million)
Table 3. World Newcastle Disease Vaccine Production Value by Region (2027-2032) & (USD Million)
Table 4. World Newcastle Disease Vaccine Production Value Market Share by Region (2021-2026)
Table 5. World Newcastle Disease Vaccine Production Value Market Share by Region (2027-2032)
Table 6. World Newcastle Disease Vaccine Production by Region (2021-2026) & (M Doses)
Table 7. World Newcastle Disease Vaccine Production by Region (2027-2032) & (M Doses)
Table 8. World Newcastle Disease Vaccine Production Market Share by Region (2021-2026)
Table 9. World Newcastle Disease Vaccine Production Market Share by Region (2027-2032)
Table 10. World Newcastle Disease Vaccine Average Price by Region (2021-2026) & (USD/K Doses)
Table 11. World Newcastle Disease Vaccine Average Price by Region (2027-2032) & (USD/K Doses)
Table 12. Newcastle Disease Vaccine Major Market Trends
Table 13. World Newcastle Disease Vaccine Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (M Doses)
Table 14. World Newcastle Disease Vaccine Consumption by Region (2021-2026) & (M Doses)
Table 15. World Newcastle Disease Vaccine Consumption Forecast by Region (2027-2032) & (M Doses)
Table 16. World Newcastle Disease Vaccine Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Newcastle Disease Vaccine Producers in 2025
Table 18. World Newcastle Disease Vaccine Production by Manufacturer (2021-2026) & (M Doses)
Table 19. Production Market Share of Key Newcastle Disease Vaccine Producers in 2025
Table 20. World Newcastle Disease Vaccine Average Price by Manufacturer (2021-2026) & (USD/K Doses)
Table 21. Global Newcastle Disease Vaccine Company Evaluation Quadrant
Table 22. World Newcastle Disease Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Newcastle Disease Vaccine Production Site of Key Manufacturer
Table 24. Newcastle Disease Vaccine Market: Company Product Type Footprint
Table 25. Newcastle Disease Vaccine Market: Company Product Application Footprint
Table 26. Newcastle Disease Vaccine Competitive Factors
Table 27. Newcastle Disease Vaccine New Entrant and Capacity Expansion Plans
Table 28. Newcastle Disease Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Newcastle Disease Vaccine Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Newcastle Disease Vaccine Production Comparison, (2021 & 2025 & 2032) & (M Doses)
Table 31. United States VS China Newcastle Disease Vaccine Consumption Comparison, (2021 & 2025 & 2032) & (M Doses)
Table 32. United States Based Newcastle Disease Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Newcastle Disease Vaccine Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Newcastle Disease Vaccine Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Newcastle Disease Vaccine Production (2021-2026) & (M Doses)
Table 36. United States Based Manufacturers Newcastle Disease Vaccine Production Market Share (2021-2026)
Table 37. China Based Newcastle Disease Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Newcastle Disease Vaccine Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Newcastle Disease Vaccine Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Newcastle Disease Vaccine Production, (2021-2026) & (M Doses)
Table 41. China Based Manufacturers Newcastle Disease Vaccine Production Market Share (2021-2026)
Table 42. Rest of World Based Newcastle Disease Vaccine Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Newcastle Disease Vaccine Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Newcastle Disease Vaccine Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Newcastle Disease Vaccine Production, (2021-2026) & (M Doses)
Table 46. Rest of World Based Manufacturers Newcastle Disease Vaccine Production Market Share (2021-2026)
Table 47. World Newcastle Disease Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Newcastle Disease Vaccine Production by Type (2021-2026) & (M Doses)
Table 49. World Newcastle Disease Vaccine Production by Type (2027-2032) & (M Doses)
Table 50. World Newcastle Disease Vaccine Production Value by Type (2021-2026) & (USD Million)
Table 51. World Newcastle Disease Vaccine Production Value by Type (2027-2032) & (USD Million)
Table 52. World Newcastle Disease Vaccine Average Price by Type (2021-2026) & (USD/K Doses)
Table 53. World Newcastle Disease Vaccine Average Price by Type (2027-2032) & (USD/K Doses)
Table 54. World Newcastle Disease Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 55. World Newcastle Disease Vaccine Production by Application (2021-2026) & (M Doses)
Table 56. World Newcastle Disease Vaccine Production by Application (2027-2032) & (M Doses)
Table 57. World Newcastle Disease Vaccine Production Value by Application (2021-2026) & (USD Million)
Table 58. World Newcastle Disease Vaccine Production Value by Application (2027-2032) & (USD Million)
Table 59. World Newcastle Disease Vaccine Average Price by Application (2021-2026) & (USD/K Doses)
Table 60. World Newcastle Disease Vaccine Average Price by Application (2027-2032) & (USD/K Doses)
Table 61. Merial Basic Information, Manufacturing Base and Competitors
Table 62. Merial Major Business
Table 63. Merial Newcastle Disease Vaccine Product and Services
Table 64. Merial Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Merial Recent Developments/Updates
Table 66. Merial Competitive Strengths & Weaknesses
Table 67. CEVA Basic Information, Manufacturing Base and Competitors
Table 68. CEVA Major Business
Table 69. CEVA Newcastle Disease Vaccine Product and Services
Table 70. CEVA Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. CEVA Recent Developments/Updates
Table 72. CEVA Competitive Strengths & Weaknesses
Table 73. QYH Biotech Basic Information, Manufacturing Base and Competitors
Table 74. QYH Biotech Major Business
Table 75. QYH Biotech Newcastle Disease Vaccine Product and Services
Table 76. QYH Biotech Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. QYH Biotech Recent Developments/Updates
Table 78. QYH Biotech Competitive Strengths & Weaknesses
Table 79. Ringpu Biology Basic Information, Manufacturing Base and Competitors
Table 80. Ringpu Biology Major Business
Table 81. Ringpu Biology Newcastle Disease Vaccine Product and Services
Table 82. Ringpu Biology Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Ringpu Biology Recent Developments/Updates
Table 84. Ringpu Biology Competitive Strengths & Weaknesses
Table 85. Yebio Basic Information, Manufacturing Base and Competitors
Table 86. Yebio Major Business
Table 87. Yebio Newcastle Disease Vaccine Product and Services
Table 88. Yebio Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Yebio Recent Developments/Updates
Table 90. Yebio Competitive Strengths & Weaknesses
Table 91. Harbin Veterinary Research Institute Basic Information, Manufacturing Base and Competitors
Table 92. Harbin Veterinary Research Institute Major Business
Table 93. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product and Services
Table 94. Harbin Veterinary Research Institute Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Harbin Veterinary Research Institute Recent Developments/Updates
Table 96. Harbin Veterinary Research Institute Competitive Strengths & Weaknesses
Table 97. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 98. Merck Animal Health Major Business
Table 99. Merck Animal Health Newcastle Disease Vaccine Product and Services
Table 100. Merck Animal Health Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. Merck Animal Health Recent Developments/Updates
Table 102. Merck Animal Health Competitive Strengths & Weaknesses
Table 103. DHN Basic Information, Manufacturing Base and Competitors
Table 104. DHN Major Business
Table 105. DHN Newcastle Disease Vaccine Product and Services
Table 106. DHN Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. DHN Recent Developments/Updates
Table 108. DHN Competitive Strengths & Weaknesses
Table 109. Zoetis Basic Information, Manufacturing Base and Competitors
Table 110. Zoetis Major Business
Table 111. Zoetis Newcastle Disease Vaccine Product and Services
Table 112. Zoetis Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 113. Zoetis Recent Developments/Updates
Table 114. Zoetis Competitive Strengths & Weaknesses
Table 115. ChengDu Tecbond Basic Information, Manufacturing Base and Competitors
Table 116. ChengDu Tecbond Major Business
Table 117. ChengDu Tecbond Newcastle Disease Vaccine Product and Services
Table 118. ChengDu Tecbond Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. ChengDu Tecbond Recent Developments/Updates
Table 120. ChengDu Tecbond Competitive Strengths & Weaknesses
Table 121. Elanco (Lohmann) Basic Information, Manufacturing Base and Competitors
Table 122. Elanco (Lohmann) Major Business
Table 123. Elanco (Lohmann) Newcastle Disease Vaccine Product and Services
Table 124. Elanco (Lohmann) Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Elanco (Lohmann) Recent Developments/Updates
Table 126. Elanco (Lohmann) Competitive Strengths & Weaknesses
Table 127. FATRO Basic Information, Manufacturing Base and Competitors
Table 128. FATRO Major Business
Table 129. FATRO Newcastle Disease Vaccine Product and Services
Table 130. FATRO Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 131. FATRO Recent Developments/Updates
Table 132. FATRO Competitive Strengths & Weaknesses
Table 133. CAVAC Basic Information, Manufacturing Base and Competitors
Table 134. CAVAC Major Business
Table 135. CAVAC Newcastle Disease Vaccine Product and Services
Table 136. CAVAC Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 137. CAVAC Recent Developments/Updates
Table 138. CAVAC Competitive Strengths & Weaknesses
Table 139. Vaksindo Basic Information, Manufacturing Base and Competitors
Table 140. Vaksindo Major Business
Table 141. Vaksindo Newcastle Disease Vaccine Product and Services
Table 142. Vaksindo Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 143. Vaksindo Recent Developments/Updates
Table 144. Vaksindo Competitive Strengths & Weaknesses
Table 145. Global Key Players of Newcastle Disease Vaccine Upstream (Raw Materials)
Table 146. Global Newcastle Disease Vaccine Typical Customers
Table 147. Newcastle Disease Vaccine Typical Distributors
Table 1. World Newcastle Disease Vaccine Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Newcastle Disease Vaccine Production Value by Region (2021-2026) & (USD Million)
Table 3. World Newcastle Disease Vaccine Production Value by Region (2027-2032) & (USD Million)
Table 4. World Newcastle Disease Vaccine Production Value Market Share by Region (2021-2026)
Table 5. World Newcastle Disease Vaccine Production Value Market Share by Region (2027-2032)
Table 6. World Newcastle Disease Vaccine Production by Region (2021-2026) & (M Doses)
Table 7. World Newcastle Disease Vaccine Production by Region (2027-2032) & (M Doses)
Table 8. World Newcastle Disease Vaccine Production Market Share by Region (2021-2026)
Table 9. World Newcastle Disease Vaccine Production Market Share by Region (2027-2032)
Table 10. World Newcastle Disease Vaccine Average Price by Region (2021-2026) & (USD/K Doses)
Table 11. World Newcastle Disease Vaccine Average Price by Region (2027-2032) & (USD/K Doses)
Table 12. Newcastle Disease Vaccine Major Market Trends
Table 13. World Newcastle Disease Vaccine Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (M Doses)
Table 14. World Newcastle Disease Vaccine Consumption by Region (2021-2026) & (M Doses)
Table 15. World Newcastle Disease Vaccine Consumption Forecast by Region (2027-2032) & (M Doses)
Table 16. World Newcastle Disease Vaccine Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Newcastle Disease Vaccine Producers in 2025
Table 18. World Newcastle Disease Vaccine Production by Manufacturer (2021-2026) & (M Doses)
Table 19. Production Market Share of Key Newcastle Disease Vaccine Producers in 2025
Table 20. World Newcastle Disease Vaccine Average Price by Manufacturer (2021-2026) & (USD/K Doses)
Table 21. Global Newcastle Disease Vaccine Company Evaluation Quadrant
Table 22. World Newcastle Disease Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Newcastle Disease Vaccine Production Site of Key Manufacturer
Table 24. Newcastle Disease Vaccine Market: Company Product Type Footprint
Table 25. Newcastle Disease Vaccine Market: Company Product Application Footprint
Table 26. Newcastle Disease Vaccine Competitive Factors
Table 27. Newcastle Disease Vaccine New Entrant and Capacity Expansion Plans
Table 28. Newcastle Disease Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Newcastle Disease Vaccine Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Newcastle Disease Vaccine Production Comparison, (2021 & 2025 & 2032) & (M Doses)
Table 31. United States VS China Newcastle Disease Vaccine Consumption Comparison, (2021 & 2025 & 2032) & (M Doses)
Table 32. United States Based Newcastle Disease Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Newcastle Disease Vaccine Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Newcastle Disease Vaccine Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Newcastle Disease Vaccine Production (2021-2026) & (M Doses)
Table 36. United States Based Manufacturers Newcastle Disease Vaccine Production Market Share (2021-2026)
Table 37. China Based Newcastle Disease Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Newcastle Disease Vaccine Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Newcastle Disease Vaccine Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Newcastle Disease Vaccine Production, (2021-2026) & (M Doses)
Table 41. China Based Manufacturers Newcastle Disease Vaccine Production Market Share (2021-2026)
Table 42. Rest of World Based Newcastle Disease Vaccine Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Newcastle Disease Vaccine Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Newcastle Disease Vaccine Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Newcastle Disease Vaccine Production, (2021-2026) & (M Doses)
Table 46. Rest of World Based Manufacturers Newcastle Disease Vaccine Production Market Share (2021-2026)
Table 47. World Newcastle Disease Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Newcastle Disease Vaccine Production by Type (2021-2026) & (M Doses)
Table 49. World Newcastle Disease Vaccine Production by Type (2027-2032) & (M Doses)
Table 50. World Newcastle Disease Vaccine Production Value by Type (2021-2026) & (USD Million)
Table 51. World Newcastle Disease Vaccine Production Value by Type (2027-2032) & (USD Million)
Table 52. World Newcastle Disease Vaccine Average Price by Type (2021-2026) & (USD/K Doses)
Table 53. World Newcastle Disease Vaccine Average Price by Type (2027-2032) & (USD/K Doses)
Table 54. World Newcastle Disease Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 55. World Newcastle Disease Vaccine Production by Application (2021-2026) & (M Doses)
Table 56. World Newcastle Disease Vaccine Production by Application (2027-2032) & (M Doses)
Table 57. World Newcastle Disease Vaccine Production Value by Application (2021-2026) & (USD Million)
Table 58. World Newcastle Disease Vaccine Production Value by Application (2027-2032) & (USD Million)
Table 59. World Newcastle Disease Vaccine Average Price by Application (2021-2026) & (USD/K Doses)
Table 60. World Newcastle Disease Vaccine Average Price by Application (2027-2032) & (USD/K Doses)
Table 61. Merial Basic Information, Manufacturing Base and Competitors
Table 62. Merial Major Business
Table 63. Merial Newcastle Disease Vaccine Product and Services
Table 64. Merial Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Merial Recent Developments/Updates
Table 66. Merial Competitive Strengths & Weaknesses
Table 67. CEVA Basic Information, Manufacturing Base and Competitors
Table 68. CEVA Major Business
Table 69. CEVA Newcastle Disease Vaccine Product and Services
Table 70. CEVA Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. CEVA Recent Developments/Updates
Table 72. CEVA Competitive Strengths & Weaknesses
Table 73. QYH Biotech Basic Information, Manufacturing Base and Competitors
Table 74. QYH Biotech Major Business
Table 75. QYH Biotech Newcastle Disease Vaccine Product and Services
Table 76. QYH Biotech Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. QYH Biotech Recent Developments/Updates
Table 78. QYH Biotech Competitive Strengths & Weaknesses
Table 79. Ringpu Biology Basic Information, Manufacturing Base and Competitors
Table 80. Ringpu Biology Major Business
Table 81. Ringpu Biology Newcastle Disease Vaccine Product and Services
Table 82. Ringpu Biology Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Ringpu Biology Recent Developments/Updates
Table 84. Ringpu Biology Competitive Strengths & Weaknesses
Table 85. Yebio Basic Information, Manufacturing Base and Competitors
Table 86. Yebio Major Business
Table 87. Yebio Newcastle Disease Vaccine Product and Services
Table 88. Yebio Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Yebio Recent Developments/Updates
Table 90. Yebio Competitive Strengths & Weaknesses
Table 91. Harbin Veterinary Research Institute Basic Information, Manufacturing Base and Competitors
Table 92. Harbin Veterinary Research Institute Major Business
Table 93. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product and Services
Table 94. Harbin Veterinary Research Institute Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Harbin Veterinary Research Institute Recent Developments/Updates
Table 96. Harbin Veterinary Research Institute Competitive Strengths & Weaknesses
Table 97. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 98. Merck Animal Health Major Business
Table 99. Merck Animal Health Newcastle Disease Vaccine Product and Services
Table 100. Merck Animal Health Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. Merck Animal Health Recent Developments/Updates
Table 102. Merck Animal Health Competitive Strengths & Weaknesses
Table 103. DHN Basic Information, Manufacturing Base and Competitors
Table 104. DHN Major Business
Table 105. DHN Newcastle Disease Vaccine Product and Services
Table 106. DHN Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. DHN Recent Developments/Updates
Table 108. DHN Competitive Strengths & Weaknesses
Table 109. Zoetis Basic Information, Manufacturing Base and Competitors
Table 110. Zoetis Major Business
Table 111. Zoetis Newcastle Disease Vaccine Product and Services
Table 112. Zoetis Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 113. Zoetis Recent Developments/Updates
Table 114. Zoetis Competitive Strengths & Weaknesses
Table 115. ChengDu Tecbond Basic Information, Manufacturing Base and Competitors
Table 116. ChengDu Tecbond Major Business
Table 117. ChengDu Tecbond Newcastle Disease Vaccine Product and Services
Table 118. ChengDu Tecbond Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. ChengDu Tecbond Recent Developments/Updates
Table 120. ChengDu Tecbond Competitive Strengths & Weaknesses
Table 121. Elanco (Lohmann) Basic Information, Manufacturing Base and Competitors
Table 122. Elanco (Lohmann) Major Business
Table 123. Elanco (Lohmann) Newcastle Disease Vaccine Product and Services
Table 124. Elanco (Lohmann) Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Elanco (Lohmann) Recent Developments/Updates
Table 126. Elanco (Lohmann) Competitive Strengths & Weaknesses
Table 127. FATRO Basic Information, Manufacturing Base and Competitors
Table 128. FATRO Major Business
Table 129. FATRO Newcastle Disease Vaccine Product and Services
Table 130. FATRO Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 131. FATRO Recent Developments/Updates
Table 132. FATRO Competitive Strengths & Weaknesses
Table 133. CAVAC Basic Information, Manufacturing Base and Competitors
Table 134. CAVAC Major Business
Table 135. CAVAC Newcastle Disease Vaccine Product and Services
Table 136. CAVAC Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 137. CAVAC Recent Developments/Updates
Table 138. CAVAC Competitive Strengths & Weaknesses
Table 139. Vaksindo Basic Information, Manufacturing Base and Competitors
Table 140. Vaksindo Major Business
Table 141. Vaksindo Newcastle Disease Vaccine Product and Services
Table 142. Vaksindo Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 143. Vaksindo Recent Developments/Updates
Table 144. Vaksindo Competitive Strengths & Weaknesses
Table 145. Global Key Players of Newcastle Disease Vaccine Upstream (Raw Materials)
Table 146. Global Newcastle Disease Vaccine Typical Customers
Table 147. Newcastle Disease Vaccine Typical Distributors
LIST OF FIGURES
Figure 1. Newcastle Disease Vaccine Picture
Figure 2. World Newcastle Disease Vaccine Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Newcastle Disease Vaccine Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 5. World Newcastle Disease Vaccine Average Price (2021-2032) & (USD/K Doses)
Figure 6. World Newcastle Disease Vaccine Production Value Market Share by Region (2021-2032)
Figure 7. World Newcastle Disease Vaccine Production Market Share by Region (2021-2032)
Figure 8. North America Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 9. Europe Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 10. Southeast Asia Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 11. Japan Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 12. China Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 13. South Korea Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 14. Newcastle Disease Vaccine Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 17. World Newcastle Disease Vaccine Consumption Market Share by Region (2021-2032)
Figure 18. United States Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 19. China Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 20. Europe Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 21. Japan Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 22. South Korea Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 23. ASEAN Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 24. India Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 25. Producer Shipments of Newcastle Disease Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 26. Global Four-firm Concentration Ratios (CR4) for Newcastle Disease Vaccine Markets in 2025
Figure 27. Global Four-firm Concentration Ratios (CR8) for Newcastle Disease Vaccine Markets in 2025
Figure 28. United States VS China: Newcastle Disease Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Newcastle Disease Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States VS China: Newcastle Disease Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States Based Manufacturers Newcastle Disease Vaccine Production Market Share 2025
Figure 32. China Based Manufacturers Newcastle Disease Vaccine Production Market Share 2025
Figure 33. Rest of World Based Manufacturers Newcastle Disease Vaccine Production Market Share 2025
Figure 34. World Newcastle Disease Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 35. World Newcastle Disease Vaccine Production Value Market Share by Type in 2025
Figure 36. Live Vaccines
Figure 37. Killed Vaccines
Figure 38. World Newcastle Disease Vaccine Production Market Share by Type (2021-2032)
Figure 39. World Newcastle Disease Vaccine Production Value Market Share by Type (2021-2032)
Figure 40. World Newcastle Disease Vaccine Average Price by Type (2021-2032) & (USD/K Doses)
Figure 41. World Newcastle Disease Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 42. World Newcastle Disease Vaccine Production Value Market Share by Application in 2025
Figure 43. Chicken
Figure 44. Duck & Goose
Figure 45. Other
Figure 46. World Newcastle Disease Vaccine Production Market Share by Application (2021-2032)
Figure 47. World Newcastle Disease Vaccine Production Value Market Share by Application (2021-2032)
Figure 48. World Newcastle Disease Vaccine Average Price by Application (2021-2032) & (USD/K Doses)
Figure 49. Newcastle Disease Vaccine Industry Chain
Figure 50. Newcastle Disease Vaccine Procurement Model
Figure 51. Newcastle Disease Vaccine Sales Model
Figure 52. Newcastle Disease Vaccine Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Newcastle Disease Vaccine Picture
Figure 2. World Newcastle Disease Vaccine Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Newcastle Disease Vaccine Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 5. World Newcastle Disease Vaccine Average Price (2021-2032) & (USD/K Doses)
Figure 6. World Newcastle Disease Vaccine Production Value Market Share by Region (2021-2032)
Figure 7. World Newcastle Disease Vaccine Production Market Share by Region (2021-2032)
Figure 8. North America Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 9. Europe Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 10. Southeast Asia Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 11. Japan Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 12. China Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 13. South Korea Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 14. Newcastle Disease Vaccine Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 17. World Newcastle Disease Vaccine Consumption Market Share by Region (2021-2032)
Figure 18. United States Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 19. China Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 20. Europe Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 21. Japan Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 22. South Korea Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 23. ASEAN Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 24. India Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 25. Producer Shipments of Newcastle Disease Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 26. Global Four-firm Concentration Ratios (CR4) for Newcastle Disease Vaccine Markets in 2025
Figure 27. Global Four-firm Concentration Ratios (CR8) for Newcastle Disease Vaccine Markets in 2025
Figure 28. United States VS China: Newcastle Disease Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Newcastle Disease Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States VS China: Newcastle Disease Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States Based Manufacturers Newcastle Disease Vaccine Production Market Share 2025
Figure 32. China Based Manufacturers Newcastle Disease Vaccine Production Market Share 2025
Figure 33. Rest of World Based Manufacturers Newcastle Disease Vaccine Production Market Share 2025
Figure 34. World Newcastle Disease Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 35. World Newcastle Disease Vaccine Production Value Market Share by Type in 2025
Figure 36. Live Vaccines
Figure 37. Killed Vaccines
Figure 38. World Newcastle Disease Vaccine Production Market Share by Type (2021-2032)
Figure 39. World Newcastle Disease Vaccine Production Value Market Share by Type (2021-2032)
Figure 40. World Newcastle Disease Vaccine Average Price by Type (2021-2032) & (USD/K Doses)
Figure 41. World Newcastle Disease Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 42. World Newcastle Disease Vaccine Production Value Market Share by Application in 2025
Figure 43. Chicken
Figure 44. Duck & Goose
Figure 45. Other
Figure 46. World Newcastle Disease Vaccine Production Market Share by Application (2021-2032)
Figure 47. World Newcastle Disease Vaccine Production Value Market Share by Application (2021-2032)
Figure 48. World Newcastle Disease Vaccine Average Price by Application (2021-2032) & (USD/K Doses)
Figure 49. Newcastle Disease Vaccine Industry Chain
Figure 50. Newcastle Disease Vaccine Procurement Model
Figure 51. Newcastle Disease Vaccine Sales Model
Figure 52. Newcastle Disease Vaccine Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
